NORDIC PHARMA LIMITED

01489084
Active Theale

Wholesale of pharmaceutical goods

29 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
N

NORDIC PHARMA LIMITED

01489084

Wholesale of pharmaceutical goods

Founded 2 Apr 1980 Active Theale, United Kingdom 29 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods

Previous Company Names

NORDIC PHARMACEUTICALS LIMITED 2 Apr 1980 — 7 May 2002
Accounts Submitted 25 Apr 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 7 May 2026 Next due 18 May 2027 10 months remaining
Net assets £32K £305K 2023 year on year
Total assets £5M £2M 2023 year on year
Total Liabilities £5M £2M 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Building 1410 Arlington Business Park Theale Reading RG7 4SA United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NORDIC PHARMA LIMITED (01489084), an active life sciences and medical technology company based in Theale, United Kingdom. Incorporated 2 Apr 1980. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£142.00

Net Assets

£32.01k

Decreased by £305.14k (-91%)

Total Liabilities

£4.58M

Increased by £2.44M (+114%)

Turnover

N/A

Employees

29

Increased by 9 (+45%)

Debt Ratio

99%

Increased by 13 (+15%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Nordic Group B.v.
100.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Frederik Dag Arfst Paulsen

Swedish

Active
Notified 19 Dec 2019
Residence Switzerland
DOB October 1950
Nature of Control
  • Significant Influence Or Control

Nordic Group B.v.

Netherlands

Active
Notified 31 May 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Nordic Group B.v.

Ceased 27 Apr 2026

Ceased

Group Structure

Group Structure

NORDIC PHARMA LIMITED Current Company
ALTACOR LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

2 leasehold 2 total
AddressTenurePrice PaidDate Added
Part Second Floor, 1410 Arlington Business Park, Theale, Reading (RG7 4SA) WEST BERKSHIRE
Leasehold-19 Jun 2023
3 Commerce Park, Brunel Road, Theale, Reading (RG7 4AB) WEST BERKSHIRE
Leasehold-16 Jan 2017
Part Second Floor, 1410 Arlington Business Park, Theale, Reading (RG7 4SA)
Leasehold
Added 19 Jun 2023
District WEST BERKSHIRE
3 Commerce Park, Brunel Road, Theale, Reading (RG7 4AB)
Leasehold
Added 16 Jan 2017
District WEST BERKSHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
3 Jun 2026Persons With Significant ControlCessation of Nordic Group B.V. as a person with significant control on 27 Apr 2026
3 Jun 2026Persons With Significant ControlNotification of a person with significant control statement
20 May 2026OfficersTermination of Anders Theodor Lofgren as director on 19 May 2026
7 May 2026Confirmation StatementConfirmation statement made on 4 May 2026 with no updates
7 May 2025Confirmation StatementConfirmation statement made on 4 May 2025 with no updates
3 Jun 2026 Persons With Significant Control

Cessation of Nordic Group B.V. as a person with significant control on 27 Apr 2026

3 Jun 2026 Persons With Significant Control

Notification of a person with significant control statement

20 May 2026 Officers

Termination of Anders Theodor Lofgren as director on 19 May 2026

7 May 2026 Confirmation Statement

Confirmation statement made on 4 May 2026 with no updates

7 May 2025 Confirmation Statement

Confirmation statement made on 4 May 2025 with no updates

Recent Activity

Latest Activity

Cessation of Nordic Group B.V. as a person with significant control on 27 Apr 2026

3 weeks ago on 3 Jun 2026

Notification of a person with significant control statement

3 weeks ago on 3 Jun 2026

Termination of Anders Theodor Lofgren as director on 19 May 2026

1 months ago on 20 May 2026

Confirmation statement made on 4 May 2026 with no updates

1 months ago on 7 May 2026

Confirmation statement made on 4 May 2025 with no updates

1 years ago on 7 May 2025